COM:AGILITIHEALTH
Agiliti Health
- Stock
Last Close
10.10
06/05 20:00
Market Cap
1.37B
Beta: -
Volume Today
26.50M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 12.27M - | 20.24M 64.97% | 41.18M 103.50% | 62.72M 52.29% | |||
average payables | 38.42M - | 38.21M 0.56% | 45.53M 19.17% | 56.51M 24.10% | |||
average receivables | 105.81M - | 130.50M 23.33% | 181.97M 39.44% | 208.53M 14.60% | |||
book value per share | -0.45 - | 4.62 1,114.65% | 4.46 3.29% | 7.41 66.05% | 7.14 3.74% | ||
capex per share | -0.43 - | -0.56 30.30% | -0.60 6.28% | -0.55 8.13% | -0.66 19.93% | -0.00 99.96% | |
capex to depreciation | -0.68 - | -0.34 50.42% | -0.34 1.19% | -0.35 1.19% | -0.49 40.53% | -0.43 12.34% | |
capex to operating cash flow | -0.63 - | -0.80 26.89% | -0.43 46.04% | -0.32 26.42% | -0.44 38.50% | -0.20 53.97% | |
capex to revenue | -0.10 - | -0.09 5.13% | -0.08 15.71% | -0.06 16.46% | -0.08 21.87% | -0.03 62.65% | |
cash per share | 0.06 - | -0.32 639.33% | 2.09 760.38% | 0.61 70.53% | 0.04 93.16% | ||
days of inventory on hand | 11.04 - | 11.55 4.68% | 20.28 75.58% | 32.87 62.07% | 37.08 12.80% | ||
days payables outstanding | 37.35 - | 33.76 9.61% | 27.89 17.38% | 32.01 14.75% | 31.28 2.27% | ||
days sales outstanding | 67.97 - | 63.33 6.82% | 72.98 15.24% | 73.55 0.78% | 67.63 8.05% | ||
debt to assets | 1.13 - | 0.59 47.88% | 0.64 8.38% | 0.51 20.42% | 0.49 4.52% | ||
debt to equity | -12.12 - | 2.09 117.24% | 2.75 31.67% | 1.43 48.13% | 1.25 12.16% | ||
dividend yield | 0.14 - | 0.00 99.50% | 0.00 52.72% | 0.00 26.65% | |||
earnings yield | -0.02 - | -0.02 24.09% | -0.01 28.83% | 0.01 162.59% | 0.01 62.91% | -0.00 100.13% | |
enterprise value | 2.74B - | 2.61B 4.76% | 2.63B 0.92% | 4.00B 52.10% | 3.34B 16.50% | ||
enterprise value over ebitda | 19.61 - | 15.62 20.34% | 12.58 19.48% | 13.51 7.43% | 12.87 4.80% | ||
ev to operating cash flow | 31.72 - | 37.26 17.45% | 19.08 48.78% | 19.04 0.25% | 16.73 12.09% | ||
ev to sales | 4.84 - | 4.25 12.19% | 3.40 19.99% | 3.85 13.24% | 2.98 22.65% | ||
free cash flow per share | 0.26 - | 0.14 43.84% | 0.79 451.59% | 1.19 49.71% | 0.85 28.83% | 0.00 99.88% | |
free cash flow yield | 0.02 - | 0.01 43.84% | 0.05 451.59% | 0.05 6.01% | 0.05 1.07% | 0.00 99.76% | |
graham net net | -5.21 - | -11.19 114.69% | -11.37 1.61% | -11.26 1.00% | -9.81 12.82% | ||
graham number | 1.61 - | 5.73 254.83% | 4.75 17.04% | 5.76 21.15% | 6.05 5.09% | ||
income quality | -2.74 - | -2.24 18.09% | -6.20 176.78% | 8.70 240.31% | 6.56 24.59% | -8.88 235.35% | |
intangibles to total assets | 0.59 - | 0.75 26.87% | 0.64 14.13% | 0.71 10.85% | 0.72 0.91% | 0 100% | |
interest coverage | -0.83 - | 0.04 105.24% | 0.59 1,241.84% | 1.95 232.36% | 1.86 4.47% | 0.77 58.60% | |
interest debt per share | 5.94 - | 10.13 70.54% | 12.90 27.35% | 11.02 14.59% | 9.32 15.46% | ||
inventory turnover | 33.07 - | 31.59 4.47% | 17.99 43.05% | 11.10 38.30% | 9.84 11.35% | ||
invested capital | -12.12 - | 2.09 117.24% | 2.75 31.67% | 1.43 48.13% | 1.25 12.16% | ||
market cap | 2.05B - | 1.62B 21.03% | 1.62B 0.03% | 2.80B 72.47% | 2.16B 22.75% | 1.07T 49,207.86% | |
net current asset value | -610.90M - | -1.03B 68.97% | -1.06B 2.60% | -1.26B 19.14% | -1.18B 6.37% | ||
net debt to ebitda | 4.90 - | 5.90 20.57% | 4.82 18.31% | 4.06 15.71% | 4.54 11.76% | ||
net income per share | -0.25 - | -0.32 24.09% | -0.22 28.83% | 0.20 188.39% | 0.23 14.72% | -0.00 100.06% | |
operating cash flow per share | 0.69 - | 0.71 2.69% | 1.39 96.98% | 1.74 24.86% | 1.51 13.41% | 0.00 99.92% | |
payables turnover | 9.77 - | 10.81 10.63% | 13.09 21.04% | 11.40 12.85% | 11.67 2.32% | ||
receivables turnover | 5.37 - | 5.76 7.32% | 5.00 13.22% | 4.96 0.77% | 5.40 8.76% | ||
research and ddevelopement to revenue | |||||||
return on tangible assets | -0.13 - | -0.08 40.01% | -0.03 57.19% | 0.03 201.24% | 0.04 32.48% | ||
revenue per share | 4.51 - | 6.20 37.35% | 7.81 26.09% | 8.59 9.98% | 8.46 1.59% | 0.01 99.90% | |
roe | 0.56 - | -0.07 112.23% | -0.05 26.41% | 0.03 153.23% | 0.03 19.18% | ||
roic | -0.02 - | 0.00 104.37% | 0.02 1,759.26% | 0.03 49.24% | 0.04 57.13% | ||
sales general and administrative to revenue | |||||||
shareholders equity per share | -0.45 - | 4.62 1,114.65% | 4.46 3.29% | 7.41 66.05% | 7.14 3.74% | ||
stock based compensation to revenue | 0.01 - | 0.01 84.12% | 0.01 36.29% | 0.01 0.57% | 0.02 24.58% | 0.02 2.64% | |
tangible asset value | -493.11M - | -751.06M 52.31% | -777.26M 3.49% | -890.21M 14.53% | -804.80M 9.59% | ||
tangible book value per share | -3.94 - | -7.59 92.88% | -7.85 3.45% | -7.36 6.22% | -6.07 17.59% | ||
working capital | 17.29M - | 16.92M 2.13% | 242.84M 1,335.46% | 149.35M 38.50% | 118.93M 20.37% |
All numbers in USD (except ratios and percentages)